BSV hosts groundbreaking ceremony for biopharma manufacturing plant in Genome Valley, Telangana

Proposed biopharma manufacturing facility at Genome Valley, Telangana to cater to domestic and export markets including regulated markets like US and EU

Bharat Serums and Vaccines hosted the groundbreaking ceremony of its new manufacturing plant at Genome Valley in Hyderabad, Telangana, in the presence of KT Rama Rao, Minister for IT, E&C, Industries & commerce, MA &UD, Govt. of Telangana. The function was attended by E V Narasimha Reddy IAS, Vice Chairman and MD, TSIIC, Shakthi M Nagappan, CEO, Telangana Lifesciences, Government of Telangana and senior leaders of BSV – Sanjiv Navangul, MD & CEO. BSV currently has a manufacturing facility in Ambernath, Maharashtra that caters to domestic and more than 80 export markets and a manufacturing facility in Aachen, Germany, that serves the international markets.

A company statement informed, “The new manufacturing facility in Genome Valley will cover an area of 10 acres and involve an investment of Rs 200 crores.  It aims to provide long-term employment opportunities to the people of the Telangana State as well as upskilling of capabilities.  With this manufacturing facility, BSV aims to significantly increase its capacity in producing injectables with the commissioning of the fill-finish formulation line in phase 1 and an additional multi-product line in phase 2 of the project. The manufacturing facility endeavors to produce world-class products that adhere to International Quality Systems while complying with the Indian regulatory norms of Schedule M as well as the Global regulatory requirements in the world. The facility will produce women health products, rabies vaccines, immunoglobulins, hormones, among others.”


Bharat Serums and Vaccinesbiopharma manufacturing facilityGenome ValleyGovt of Telangana
Comments (0)
Add Comment